Endologix, Inc. reaffirmed revenue guidance for the first quarter ending March 31, 2019. For the quarter the company anticipates revenue of approximately $35 million. For the year, the company expects its previously issued annual guidance and continues to expect 2019 revenue of at least $140 million.